Indication
Complicated E. coli peritonitis
Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity. Read more about Complicated E. coli peritonitis
103 drugs 69 manufacturers
Drugs that treat it
Common Complicated E. coli peritonitis therapies.
CEFEPIME HCL
CEFEPIME HCL
CEFEPIME HCL
ERTAPENEM (ertapenem sodium)
ERTAPENEM (ertapenem sodium)
ERTAPENEM (ertapenem sodium)
ERTAPENEM (ertapenem sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonComplicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity.
Most commonly arising as secondary peritonitis from gastrointestinal perforation, anastomotic leak, or as an advanced complication of peritoneal dialysis and end-stage liver disease, it directly affects the gastrointestinal and peritoneal systems.
Pathophysiologically, disruption of anatomical barriers or transmural bacterial translocation allows virulent *E.
coli* to inoculate the peritoneal space, triggering intense neutrophilic exudation, abscess formation, and systemic endotoxemia.
Clinically, it presents with severe abdominal pain, diffuse guarding or rigidity, fever, and leukocytosis, frequently progressing to systemic inflammatory response syndrome, sepsis, or septic shock without prompt surgical source control and directed antimicrobial therapy.
- fda.gov
Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity
- fda.gov
Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity
- uspharmacist.com
Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity Most commonly arising as secondary peritonitis from gastrointestinal perforation, anastomotic leak, or as an advanced complication of peritoneal dialysis and end-stage liver disease, it directly affects the gastrointestinal and peritoneal systems Pathophysiologically, disruption...
- mayoclinic.org
Most commonly arising as secondary peritonitis from gastrointestinal perforation, anastomotic leak, or as an advanced complication of peritoneal dialysis and end-stage liver disease, it directly affects the gastrointestinal and peritoneal systems Clinically, it presents with severe abdominal pain, diffuse guarding or rigidity, fever, and leukocytosis, frequently progressing to systemic inflammatory response syndrome, sepsis, or septic shock without prompt surgical source control and directed ant...
- jefferson.edu
Pathophysiologically, disruption of anatomical barriers or transmural bacterial translocation allows virulent *E. coli* to inoculate the peritoneal space, triggering intense neutrophilic exudation, abscess formation, and systemic endotoxemia
- clevelandclinic.org
Clinically, it presents with severe abdominal pain, diffuse guarding or rigidity, fever, and leukocytosis, frequently progressing to systemic inflammatory response syndrome, sepsis, or septic shock without prompt surgical source control and directed antimicrobial therapy
Personalize your experience
Follow Complicated E. coli peritonitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.